RNS Number : 2851L
Latham(James) PLC
11 January 2021
James Latham plc
("James Latham" or "the Company")
Director/PDMR Dealings
The Company announces that, on 11 January 2021, Andrew Wright, Managing Director, sold 1,897 ordinary shares of 25 pence each in the Company ("Ordinary Shares") and his wife Mary Wright sold 1,834 Ordinary Shares at a price of 925p per share. Following this sale, Andrew Wright's resultant beneficial shareholding in the Company is 28,111 Ordinary Shares representing 0.14% of the issued share capital of the Company.
For further information please visit www.lathams.co.uk or contact:
James Latham plc
Tel: 01442 849 100
Nick Latham, Chairman
David Dunmow, Finance Director
SP Angel Corporate Finance LLP
Matthew Johnson / Charlie Bouverat (Corporate Finance)
Tel: 0203 470 0470
Abigail Wayne (Corporate Broking)
The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
1. Andrew Wright 2. Mary Wright
2
Reason for the notification
a)
Position/status
1.Managing Director
2. PCA to Andrew Wright
b)
Initial notification /Amendment
InitialNotification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
James Latham plc
b)
LEI
2138008M4LVEDHBPBU41
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary shares of 25p each
Identification code
GB00B04NP100
b)
Nature of the transaction
Sale of shares
c)
Price(s) and volume(s)
Price(s)
Volume(s)
1.
925p
2.
925p
1.
1,897
2.
1,834
d)
Aggregated information
- Aggregated volume
As above
- Price
e)
Date of the transaction
11 January 2021
f)
Place of the transaction
XLON
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHEALFFFFXFEFA
